Table TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006 [see all tables in this series...]

Part (viii) Percentage distribution of route of administration amongst all clients with hypnotics and sedatives as primary drug

Country		Inject	Smoke/inhale	Eat/drink	Sniff	Others	Base (known status)	Status unknown
Bulgaria		0.0	0.0	100.0	0.0	0.0	1	0
Czech Republic		4.0	0.0	96.0	0.0	0.0	25	0
Denmark		0.0	2.7	97.3	0.0	0.0	37	5
Germany		3.5	1.6	87.2	0.8	6.9	3029	3447
Ireland		0.0	1.5	98.5	0.0	0.0	67	1
Greece		0.0	11.1	88.9	0.0	0.0	27	0
Spain	(1)	0.4	0.5	97.8	0.2	1.1	557	61
France		3.0	2.3	90.4	1.8	2.5	438	203
Italy		14.0	11.9	62.6	9.8	1.7	235	0
Cyprus		0.0	50.0	50.0	0.0	0.0	2	0
Lithuania		29.7	0.0	70.3	0.0	0.0	74	6
Hungary		2.5	0.9	95.8	0.0	0.9	570	0
Malta		0.0	0.0	100.0	0.0	0.0	3	0
Netherlands	(2)	0.0	1.2	96.4	0.6	1.8	165	7
Austria		0.0	0.0	100.0	0.0	0.0	75	0
Slovakia		0.0	0.0	100.0	0.0	0.0	13	1
Finland		2.7	0.0	96.5	0.9	0.0	113	4
Sweden		0.5	1.0	96.0	1.0	1.5	202	3
United Kingdom	(3)	0.7	1.0	93.5	0.3	4.5	2091	140
Total		2.7	1.6	90.5	0.9	4.4	7724	3878

Notes:

 Only countries where there are clients reported with hypnotics and sedatives as primary drug are shown. 

 (1) Data refer to 2005. 

 (2) Data refer to outpatient treatment centres and low-threshold agencies. 

 (3) Data refer to collection period between 1.4.2005 and 31.3.2006. 

Sources:

 Reitox national reports 2007 — TDI — outpatient treatment centres. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)